Has Katherine Palmisano, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,725 in general payments to Katherine Palmisano, MD across 96 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Katherine Palmisano, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Katherine Palmisano, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Katherine Palmisano, MD

Internal Medicine · Indianapolis, INNPI 1467815134

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,513 of the $4,725 with a category attached, or 74.3%. 11 manufacturers reported payments, led by Smith+Nephew at 58.6% of the total. Reporting peaked in 2024 at $2,399 and has fallen 59.1% since, to $981 in 2025. Among internal medicine clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,725in general payments, 2019–2025

Across 96 payments — averaging $49.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$3K
Kerecis Limited$477
Tactile Systems Technology Inc$381
Organogenesis Inc.$267
Urgo Medical North America, LLC$188
Stryker$147
plus $496 from 5 others

What the payments were for

Travel & lodging$1,20225%
Food & beverage$3,51374%
Education$100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	61	$2,769
Kerecis Limited	10	$477
Tactile Systems Technology Inc	8	$381
Organogenesis Inc.	7	$267
Urgo Medical North America, LLC	2	$188
Stryker	1	$147
Bioventus LLC	1	$144
Angiodynamics, Inc.	2	$142
Convatec Inc.	2	$141
Terumo Medical Corporation	1	$53
Hartmann USA, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ACTICOAT 4" X 4"$1,061
PICO$1,061
Oasis$1,054
Allevyn Gentle Border 10 x 10cm Ctn 10$933
Versajet$933
Kerecis Omega3 SurgiClose$895
Grafix$733
Kerecis Omega3 GraftGuide$298
Kerecis Omega3 Marigen$298
Flexitouch Plus$245
VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP$184
FLOWTRIEVER CATHETER, S$147
CT THROMBECTOMY SYSTEM KIT$147
GRAFIX PL$143
ENTRE$131
ALLEVYN LIFE L 15.4X15.4 CTN10$129
RENASYS TOUCH$129
InnovaMatrix AC$124
AngioVac$122
Stravix$121

How this compares

$4,725 in reported general payments places this provider in the 90th percentile of 1,747 internal medicine providers in Indiana.

See all internal medicine providers in Indiana →

Medicare billing

Part B allowed, 2024

$53,716

Medicare patients

215

Services billed

615

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	12	$7,052
Paliperidone ErPaliperidone	12	$2,173
Trazodone Hcl	14	$327
Pantoprazole Sodium	14	$272
Cefdinir	11	$230
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	16	$143
Metoprolol Tartrate	16	$76
Furosemide	12	$73
Oxycodone Hcl	11	$52

Paid to pharmacies, not to this prescriber.

Other internal medicine in Indianapolis

Raj VuppalanchiIndianapolis$279K
Napoleon MamintaIndianapolis$116K
Allon FriedmanIndianapolis$111K
John AyresIndianapolis$107K
Awaneesh KumarIndianapolis$68K
Justin FieldIndianapolis$49K
Misty ShieldsIndianapolis$39K
Volodymyr OliynykIndianapolis$38K
Sapan BhutaIndianapolis$30K
Azizullah BeranIndianapolis$29K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →